Trial · NCT00654940
Results by group22
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 22
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline to Treatment Week 2 in Daily Pain Rating Scale | Period 1: Pregabalin | Baseline | 6.03 | Standard Deviation 1.29 | scores on scale |
| Change From Baseline to Treatment Week 2 in Daily Pain Rating Scale | Period 1: Placebo | Baseline | 5.24 | Standard Deviation 2.03 | scores on scale |
| Change From Baseline to Treatment Week 2 in Daily Pain Rating Scale | Period 2: Placebo | Baseline | 5.96 | Standard Deviation 0.88 | scores on scale |
| Change From Baseline to Treatment Week 2 in Daily Pain Rating Scale | Period 2: Pregabalin | Baseline | 5.31 | Standard Deviation 1.82 | scores on scale |
| Change From Baseline to Treatment Week 2 in Daily Pain Rating Scale | Period 1: Pregabalin | Treatment Week 2 | 5.40 | Standard Deviation 1.34 | scores on scale |
| Change From Baseline to Treatment Week 2 in Daily Pain Rating Scale | Period 1: Placebo | Treatment Week 2 | 5.08 | Standard Deviation 2.05 | scores on scale |
| Change From Baseline to Treatment Week 2 in Daily Pain Rating Scale | Period 2: Placebo | Treatment Week 2 | 6.11 | Standard Deviation 1.20 | scores on scale |
| Change From Baseline to Treatment Week 2 in Daily Pain Rating Scale | Period 2: Pregabalin | Treatment Week 2 | 4.38 | Standard Deviation 2.02 | scores on scale |
| Change From Baseline to Treatment Week 2 in Daily Pain Rating Scale | Period 1: Pregabalin | Change from Baseline | -0.63 | Standard Deviation 1.01 | scores on scale |
| Change From Baseline to Treatment Week 2 in Daily Pain Rating Scale | Period 1: Placebo | Change from Baseline | -0.16 | Standard Deviation 0.97 | scores on scale |
| Change From Baseline to Treatment Week 2 in Daily Pain Rating Scale | Period 2: Placebo | Change from Baseline | 0.16 | Standard Deviation 1.07 | scores on scale |
| Change From Baseline to Treatment Week 2 in Daily Pain Rating Scale | Period 2: Pregabalin | Change from Baseline | -0.93 | Standard Deviation 1.24 | scores on scale |
| Neuropathic Pain Symptom Inventory (NPSI) | Pregabalin/Placebo | Week 0 (Baseline: Treatment Period 1) | 5.31 | Standard Deviation 3.50 | scores on scale |
| Neuropathic Pain Symptom Inventory (NPSI) | Placebo/Pregabalin | Week 0 (Baseline: Treatment Period 1) | 5.25 | Standard Deviation 2.38 | scores on scale |
| Neuropathic Pain Symptom Inventory (NPSI) | Pregabalin/Placebo | Week 2 (End of Treatment: Treatment Period 1) | 5.31 | Standard Deviation 3.30 | scores on scale |
| Neuropathic Pain Symptom Inventory (NPSI) | Placebo/Pregabalin | Week 2 (End of Treatment: Treatment Period 1) | 4.91 | Standard Deviation 2.30 | scores on scale |
| Neuropathic Pain Symptom Inventory (NPSI) | Pregabalin/Placebo | Week 4 (Baseline: Treatment Period 2) | 4.33 | Standard Deviation 3.14 | scores on scale |
| Neuropathic Pain Symptom Inventory (NPSI) | Placebo/Pregabalin | Week 4 (Baseline: Treatment Period 2) | 5.27 | Standard Deviation 2.45 | scores on scale |
| Neuropathic Pain Symptom Inventory (NPSI) | Pregabalin/Placebo | Week 6 (End of Treatment: Treatment Period 2) | 4.75 | Standard Deviation 3.39 | scores on scale |
| Neuropathic Pain Symptom Inventory (NPSI) | Placebo/Pregabalin | Week 6 (End of Treatment: Treatment Period 2) | 3.00 | Standard Deviation 2.24 | scores on scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00654940/results